Scinovex
review Open AccessTop 1% cited

Obesity and cognitive decline: role of inflammation and vascular changes

Frontiers in Neuroscience · 2014 · Vol. 8 · pp. 375–375
Jason NguyenSimon KillcrossTrisha A. Jenkins

Abstract

The incidence of obesity in middle age is increasing markedly, and in parallel the prevalence of metabolic disorders including cardiovascular disease and type II diabetes is also rising. Numerous studies have demonstrated that both obesity and metabolic disorders are associated with poorer cognitive performance, cognitive decline, and dementia. In this review we discuss the effects of obesity on cognitive performance, including both clinical and preclinical observations, and discuss some of the potential mechanisms involved, namely inflammation and vascular and metabolic alterations.

Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and ObesityApelin-related biomedical researchObesityCognitive declineDementiaMedicineMetabolic syndromeCognitionInflammationDiabetes mellitusType 2 diabetesDisease
Citations
416
FWCI
13.94
field-weighted impact
References
151
Percentile
99%
vs. same field & year
Citations per year
References
Cholinesterase inhibitors for Alzheimer's disease
Cochrane Database of Systematic Reviews · 2006 · 1,851 citations
Obesity is associated with macrophage accumulation in adipose tissue
Journal of Clinical Investigation · 2003 · 8,580 citations
Astrocytes: biology and pathology
Acta Neuropathologica · 2009 · 5,055 citations
Midlife and Late-Life Obesity and the Risk of Dementia
Archives of Neurology · 2009 · 770 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.